Attributes | Values |
---|
rdf:type
| |
Description
| - The article deals with the assesment of cardiac toxicity of antracycline trestment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK - MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB). GPBB could be a new promising marker for detection of anthracycline-related cardiotoxicity and probably superior to cardiac troponins.
- The article deals with the assesment of cardiac toxicity of antracycline trestment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK - MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB). GPBB could be a new promising marker for detection of anthracycline-related cardiotoxicity and probably superior to cardiac troponins. (en)
- Článek pojednává o hodnocení kardiální toxicity antracyklinů pomocí sady šesti biomarkerů kardiálního poškození (myoglobin, CK - MB mass, cTnT, cTnI, H-FABP, BPBB). Stanovení GPBB by se mohlo stát nadějným ukazatelem pro detekci kardiotoxicity antracyklinů a možná i lepším než kardiální proponiny. (cs)
|
Title
| - Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia
- Použití mnohočetných biomarkerů pro hodnocení kardiotoxicity vyvolané antracykliny u pacientů s akutní myeloidní leukémií (cs)
- Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia (en)
|
skos:prefLabel
| - Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia
- Použití mnohočetných biomarkerů pro hodnocení kardiotoxicity vyvolané antracykliny u pacientů s akutní myeloidní leukémií (cs)
- Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia (en)
|
skos:notation
| - RIV/60162694:G44__/08:00002058!RIV09-MO0-G44_____
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/08:00002058
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - cardiac biomarkers; glycogen phosphorylase BB; cardiotoxicity; anthracyclines; chemoterapy; acute myeloid leukemia (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Horáček, Jan
- Malý, J.
- Tichý, Miloš
- Ulrychová, M.
- Jebavý, Ladislav
- Pudil, R.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |